James Bouras
Psychiatric/Mental Health · Everett, MANPI 1750662532
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 235 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 18.6% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 235 payments — averaging $24.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- Axsome Therapeutics, Inc.$723
- Lundbeck LLC$613
- Neos Therapeutics, LP$588
- Corium, LLC$503
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$423
- plus $2K from 9 others
What the payments were for
- Food & beverage$5,667100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 36 | $1,054 |
| Axsome Therapeutics, Inc. | 36 | $723 |
| Lundbeck LLC | 20 | $613 |
| Neos Therapeutics, LP | 28 | $588 |
| Corium, LLC | 18 | $503 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 14 | $423 |
| Sunovion Pharmaceuticals Inc. | 21 | $384 |
| Otsuka America Pharmaceutical, Inc. | 18 | $345 |
| AbbVie | 16 | $339 |
| Avanir Pharmaceuticals, Inc. | 13 | $307 |
| Collegium Pharmaceutical, Inc. | 9 | $179 |
| Alkermes, Inc. | 1 | $79 |
| Vanda Pharmaceuticals Inc. | 3 | $71 |
| Johnson & Johnson | 1 | $36 |
| Idorsia Pharmaceuticals US Inc | 1 | $23 |
How this compares
$5,667 in reported general payments places this provider in the 95th percentile of 1,284 psychiatric/mental health providers in Massachusetts.
See all psychiatric/mental health providers in Massachusetts →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 14 | $1,756 |
| Quetiapine Fumarate | 25 | $1,183 |
| Alprazolam | 91 | $776 |
| Bupropion XlBupropion Hcl | 25 | $745 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 21 | $612 |
| Trazodone Hcl | 37 | $492 |
| Lamotrigine | 31 | $323 |
| Methylphenidate ErMethylphenidate Hcl | 13 | $320 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 20 | $286 |
| Clonazepam | 38 | $277 |
| Fluoxetine Hcl | 17 | $253 |
| Lorazepam | 31 | $220 |
| Sertraline Hcl | 13 | $212 |
| Methylphenidate Hcl | 13 | $60 |
| Mirtazapine | 14 | $59 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Everett
- Brianne LienkampMarion$121K
- Ashley BakerQuincy$54K
- Brian BanksPembroke$47K
- Anne-Margaret BotelhoMattapoisett$46K
- Matthew PeculisWalpole$41K
- Sherrie UrenaWorcester$21K
- Irina DauphineeHanover$18K
- Schree PettigrewNew Bedford$18K
- Sherryl RosenLynn$16K
- Kevin NardoneWorcester$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.